QRSVX
Price
$44.31
Change
-$0.10 (-0.23%)
Updated
Oct 6 closing price
Net Assets
1.07B
VISVX
Price
$50.54
Change
-$0.11 (-0.22%)
Updated
Oct 6 closing price
Net Assets
59.14B
Interact to see
Advertisement

QRSVX vs VISVX

Header iconQRSVX vs VISVX Comparison
Open Charts QRSVX vs VISVXBanner chart's image
FPA Queens Road Small Cap Value I
Price$44.31
Change-$0.10 (-0.23%)
VolumeN/A
Net Assets1.07B
Vanguard Small Cap Value Index I
Price$50.54
Change-$0.11 (-0.22%)
VolumeN/A
Net Assets59.14B
QRSVX vs VISVX Comparison Chart in %
View a ticker or compare two or three
VS
QRSVX vs. VISVX commentary
Oct 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QRSVX is a Buy and VISVX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 59.1B vs. QRSVX (1.07B). VISVX pays higher dividends than QRSVX: VISVX (1.88) vs QRSVX (0.68). QRSVX was incepted earlier than VISVX: QRSVX (23 years) vs VISVX (27 years). QRSVX (0.99) is less costly to investors than VISVX (0.19). VISVX is a more actively managed with annual turnover of: 16.00 vs. QRSVX (15.00). QRSVX has a lower initial minimum investment than VISVX: QRSVX (1500) vs VISVX (3000). QRSVX annual gain was more profitable for investors over the last year : 12.76 vs. VISVX (6.40). VISVX return over 5 years is better than : 83.02 vs. QRSVX (76.22).
QRSVXVISVXQRSVX / VISVX
Total Expense Ratio0.990.19521%
Annual Report Gross Expense Ratio0.990.19521%
Fund Existence23 years27 years-
Gain YTD13.8436.932200%
Front LoadN/AN/A-
Min. Initial Investment1500300050%
Min. Initial Investment IRAN/AN/A-
Net Assets1.07B59.1B2%
Annual Yield % from dividends0.681.8836%
Returns for 1 year12.766.40199%
Returns for 3 years48.1944.92107%
Returns for 5 years76.2283.0292%
Returns for 10 years90.79114.3579%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ENTA11.351.02
+9.87%
Enanta Pharmaceuticals
KLAC1139.7138.16
+3.46%
KLA Corp
NMM44.57-0.23
-0.51%
Navios Maritime Partners LP
LRN140.65-2.91
-2.03%
Stride
ADAP0.13-0.02
-12.90%
Adaptimmune Therapeutics plc